Literature DB >> 20628773

Correlation of RDC/TMD axis I diagnoses and axis II pain-related disability. A multicenter study.

Daniele Manfredini1, Jari Ahlberg, Ephraim Winocur, Luca Guarda-Nardini, Frank Lobbezoo.   

Abstract

As part of an ongoing multicenter investigation involving four highly specialized tertiary clinics for temporomandibular disorders (TMD) treatment, retrospective analysis of Research Diagnostic Criteria for TMD (RDC/TMD) axis I and axis II data gathered on clinic and community cases were assessed with a twofold aim: (1) to search for a correlation between axis I diagnoses and axis II pain-related disability, and (2) to identify clinical (axis I) and psychosocial (axis II) predictors of high pain-related disability. Two samples of patients seeking treatment for TMD (clinic cases, N = 1,312) and a sample of general population subjects (community cases, N = 211) underwent a thorough assessment in accordance with the RDC/TMD version 1.0 [1] guidelines to receive both axis I and axis II diagnoses. Spearman's test was performed to assess the level of correlation between axis I diagnoses and Graded Chronic Pain Scale (GCPS) pain-related disability. A stepwise multiple logistic regression model was used to identify the significant associations between 12 clinical and psychosocial predictors and the presence of high pain-related disability. Axis I findings were related with pain-related impairment (GCPS scores) in the overall study sample including both clinic community cases (Spearman correlation = 0.129, p = 0.000), but the results of the correlation analyses performed on the clinic sample alone were not significant (Spearman correlation = -0.018, p = 0.618). Predictors for high disability were related to axis II findings (severe depression and somatization) or psychosocial aspects related to the pain experience (pain lasting from more than 6 months; treatment-seeking behavior), while none of the axis I diagnoses remained in the final logistic regression model. The final model predicted the level of pain-related impairment at a fair level (R(2) = 26.7%). The correlation between axis I diagnoses and pain-related impairment is not significant in the patients populations. Treatment-seeking behavior and other factors related with the pain experience are likely to be more important than the physical findings to determine the degree of psychosocial impairment.

Entities:  

Mesh:

Year:  2010        PMID: 20628773     DOI: 10.1007/s00784-010-0444-4

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  46 in total

1.  Psychosocial profiles of diagnostic subgroups of temporomandibular disorder patients.

Authors:  Daniel R Reissmann; Mike T John; Robert W Wassell; Andreas Hinz
Journal:  Eur J Oral Sci       Date:  2008-06       Impact factor: 2.612

Review 2.  The role of psychosocial factors in temporomandibular disorders.

Authors:  G B Rollman; J M Gillespie
Journal:  Curr Rev Pain       Date:  2000

3.  Depression and somatization in patients with temporomandibular disorders.

Authors:  Adrian U J Yap; Keson B C Tan; Ee Kiam Chua; Hee Hon Tan
Journal:  J Prosthet Dent       Date:  2002-11       Impact factor: 3.426

4.  A randomized clinical trial using research diagnostic criteria for temporomandibular disorders-axis II to target clinic cases for a tailored self-care TMD treatment program.

Authors:  Samuel F Dworkin; Kimberly H Huggins; Leanne Wilson; Lloyd Mancl; Judith Turner; Donna Massoth; Linda LeResche; Edmond Truelove
Journal:  J Orofac Pain       Date:  2002

5.  The Research Diagnostic Criteria for Temporomandibular Disorders. VI: future directions.

Authors:  Gary C Anderson; Yoly M Gonzalez; Richard Ohrbach; Edmond L Truelove; Earl Sommers; John O Look; Eric L Schiffman
Journal:  J Orofac Pain       Date:  2010

6.  Diagnoses based on the Research Diagnostic Criteria for Temporomandibular Disorders in a biracial population of young women.

Authors:  Octavia Plesh; Sandra E Sinisi; Patricia B Crawford; Stuart A Gansky
Journal:  J Orofac Pain       Date:  2005

7.  Differential treatment responses of TMD patients as a function of psychological characteristics.

Authors:  Thomas E Rudy; Dennis C Turk; John A Kubinski; Hussein S Zaki
Journal:  Pain       Date:  1995-04       Impact factor: 6.961

8.  Symptoms, signs, and clinical diagnoses according to the research diagnostic criteria for temporomandibular disorders among Finnish multiprofessional media personnel.

Authors:  Mikko A Rantala; Jari Ahlberg; Tuija I Suvinen; Aslak Savolainen; Mauno Könönen
Journal:  J Orofac Pain       Date:  2003

9.  Translating the Research Diagnostic Criteria for Temporomandibular Disorders into Malay: evaluation of content and process.

Authors:  Suan-Phaik Khoo; Adrian U Jin Yap; Yiong Huak Chan; Awang M Bulgiba
Journal:  J Orofac Pain       Date:  2008

10.  Diagnostic sub-types, psychological distress and psychosocial dysfunction in southern Chinese people with temporomandibular disorders.

Authors:  L T K Lee; R W K Yeung; M C M Wong; A S McMillan
Journal:  J Oral Rehabil       Date:  2008-03       Impact factor: 3.837

View more
  14 in total

1.  Dental Angle class asymmetry and temporomandibular disorders.

Authors:  Daniele Manfredini; Luca Lombardo; Giuseppe Siciliani
Journal:  J Orofac Orthop       Date:  2017-01-13       Impact factor: 1.938

2.  Comparative effectiveness of traditional Chinese medicine and psychosocial care in the treatment of temporomandibular disorders-associated chronic facial pain.

Authors:  Cheryl Ritenbaugh; Richard Hammerschlag; Samuel F Dworkin; Mikel G Aickin; Scott D Mist; Charles R Elder; Richard E Harris
Journal:  J Pain       Date:  2012-10-09       Impact factor: 5.820

3.  A Preliminary Study of Associations between Discomfort Intolerance, Pain Severity/Interference, and Frequency of Cannabis Use among Individuals with Chronic Pain.

Authors:  Jesse D Kosiba; Luke D Mitzel; Emily L Zale; Michael J Zvolensky; Joseph W Ditre
Journal:  Addict Res Theory       Date:  2019-03-23

4.  Characteristics Associated With High-Impact Pain in People With Temporomandibular Disorder: A Cross-Sectional Study.

Authors:  Vanessa E Miller; Charles Poole; Yvonne Golightly; Deborah Barrett; Ding-Geng Chen; Richard Ohrbach; Joel D Greenspan; Roger B Fillingim; Gary D Slade
Journal:  J Pain       Date:  2018-10-04       Impact factor: 5.820

5.  Signs and symptoms of first-onset TMD and sociodemographic predictors of its development: the OPPERA prospective cohort study.

Authors:  Gary D Slade; Eric Bair; Joel D Greenspan; Ronald Dubner; Roger B Fillingim; Luda Diatchenko; William Maixner; Charles Knott; Richard Ohrbach
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

6.  Dental malocclusion is not related to temporomandibular joint clicking: a logistic regression analysis in a patient population.

Authors:  Daniele Manfredini; Giuseppe Perinetti; Luca Guarda-Nardini
Journal:  Angle Orthod       Date:  2013-08-19       Impact factor: 2.079

7.  The evaluation of agreement between high-frequency ultrasonography and research diagnostic criteria for the diagnosis of temporomandibular joint internal derangements.

Authors:  Ravza Eraslan; Kerem Kılıç; Meryem Etöz; Damla Soydan
Journal:  J Indian Prosthodont Soc       Date:  2020-10-08

8.  Identifying potential predictors of pain-related disability in Turkish patients with chronic temporomandibular disorder pain.

Authors:  Meltem Ozdemir-Karatas; Kadriye Peker; Ali Balık; Omer Uysal; Erman B Tuncer
Journal:  J Headache Pain       Date:  2013-03-14       Impact factor: 7.277

9.  The contribution of computerized axiography to the functional evaluation of the temporomandibular joint: a case report.

Authors:  Alexandra Maria Botos; Anca Stefania Mesaros; Adela Ioana Zimbran
Journal:  Clujul Med       Date:  2016-07-28

10.  Efficacy and Safety of Botulinum Toxin Type A on Persistent Myofascial Pain: A Randomized Clinical Trial.

Authors:  Giancarlo De la Torre Canales; Natalia Alvarez-Pinzon; Victor Ricardo Manuel Muñoz-Lora; Leonardo Vieira Peroni; Amanda Farias Gomes; Alfonso Sánchez-Ayala; Francisco Haiter-Neto; Daniele Manfredini; Célia Marisa Rizzatti-Barbosa
Journal:  Toxins (Basel)       Date:  2020-06-15       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.